Healthcare stocks are lower with the NYSE Healthcare Sector
Index off 0.3% but with shares of healthcare companies in the
S&P 500 falling nearly 0.7% as a group.
In company news, GW Pharmaceuticals (
) is up 18.3% at $20.91, easing slightly from a new 52-week high of
$22.70 that followed the the UK-based maker of cannabinoid
prescription medicines Wednesday reporting data from new studies
showing the long-term effectiveness of its Sativex drug candidate
improving spasticity symptoms in patients with multiple sclerosis
with no additional safety concerns identified in clinical
The data is being presented Wednesday at the 29th Congress of
the European Committee for Treatment and Research in Multiple
Sclerosis in Copenhagen, Denmark.
Sativex also is being developed by GWPH for the treatment of
In other sector news,
(+) OMER, (+15.3%) Identifies six new lass A orphan G
protein-coupled receptors linked to neurologic disorders,
cardiovascular disease and cancer, paving the way for developing
drugs that target those receptors.
(-) ZLCS, (-10.4%) Completes 1-for-6 reverse stock split at
12:01 a.m. today as part of efforts to lift share price well above
$1 minimum needed for continued Nasdaq listing.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.